<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="8721">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00810641</url>
  </required_header>
  <id_info>
    <org_study_id>KONOS</org_study_id>
    <nct_id>NCT00810641</nct_id>
  </id_info>
  <brief_title>Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo</brief_title>
  <acronym>BPPV-HC</acronym>
  <official_title>Randomized Multicenter Study of Treatment of Horizontal Canal Benign Paroxysmal Positional Vertigo</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chonbuk National University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chonbuk National University</source>
  <oversight_info>
    <authority>Korea: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to compare the immediate efficacies of each treatment
      maneuvers in treatment of apogeotropic horizontal canal benign paroxysmal positional vertigo
      (HC-BPPV).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized prospective study of patients with HC-BPPV. Patients with apogeotropic type of
      HC-BPPV were randomized to one of each three treatment groups at their first clinic visit.
      These groups included the Gufoni maneuver, head-shaking maneuver, and sham group in
      apogeotropic HC-BPPV. Responsiveness of treatment maneuver was determined by positioning
      maneuver immediately after each treatment method based on resolves of vertigo and positional
      nystagmus.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo: A Randomized Clinical Trial</measure>
    <time_frame>one hour</time_frame>
    <safety_issue>No</safety_issue>
    <description>The immediate treatment response was determined by participating neurologists in each clinic without knowing the maneuver applied to each patient from 30 minutes to one hour after initial maneuver. The absence of both vertigo and nystagmus was required to determine a resolution.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">157</enrollment>
  <condition>HC-BPPV</condition>
  <arm_group>
    <arm_group_label>Gufoni maneuver</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Gufoni maneuver for apogeotropic HC-BPPV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Headshaking maneuver</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>headshaking maneuver for apogeotropic HC BPPV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham maneuver</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>sham maneuver for apogeotropic HC BPPV</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Gufoni maneuver</intervention_name>
    <description>For Gufoni maneuver,16,18 the patient was quickly brought down to the side-lying position on the affected ear from the sitting position. After one minute in this position, the head of the patient was quickly turned 45O upward, so that the nose directed upward. Approximately 2 minutes later, the patient was returned to the upright position (Figure 2A).</description>
    <arm_group_label>Gufoni maneuver</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Head-shaking maneuver</intervention_name>
    <description>For head-shaking maneuver,15 patients were brought into a sitting position. After pitching the head forward by approximately 30O, we moved the head sideways in a sinusoidal fashion at an approximate rate of 3 Hz for 15 seconds.</description>
    <arm_group_label>Headshaking maneuver</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>sham maneuver</intervention_name>
    <description>For the sham maneuver, patients quickly lied on the unaffected side, and returned to the sitting position after one minute.</description>
    <arm_group_label>sham maneuver</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  a history of brief episodes of positional vertigo,

          -  direction-changing horizontal nystagmus beating toward the uppermost (apogeotropic
             nystagmus) or undermost (geotropic nystagmus) ear in both the lateral head turning
             positions,

          -  no spontaneous nystagmus during upright sitting position, and

          -  absence of identifiable central nervous system disorders that could explain the
             positional vertigo and nystagmus.

        Exclusion Criteria:

          -  central positional nystagmus with identifiable CNS lesions that could explain the
             positional nystagmus
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Chonbuk National University Hospital</name>
      <address>
        <city>Jeonju</city>
        <state>Cholabuk-do</state>
        <zip>560-712</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Kyoungki-do</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2011</verification_date>
  <lastchanged_date>May 31, 2011</lastchanged_date>
  <firstreceived_date>December 17, 2008</firstreceived_date>
  <firstreceived_results_date>May 25, 2011</firstreceived_results_date>
  <responsible_party>
    <name_title>KONOS</name_title>
    <organization>Korean neuro-ophthalmology and neuro-otology society</organization>
  </responsible_party>
  <keyword>BPPV(benign paroxysmal positional vertigo)</keyword>
  <keyword>HC-BPPV(BPPV involving the horizontal semicircular canal)</keyword>
  <keyword>Nystagmus</keyword>
  <keyword>Treatment outcome</keyword>
  <keyword>Horizontal Canal Benign Paroxysmal Positional Vertigo</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vertigo</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Between February 2009 and October 2009, consecutive patients with a diagnosis of apogeotropic HC-BPPV were recruited from nationwide 10 Dizziness Clinics in Korea.</recruitment_details>
      <pre_assignment_details>We defined the transition as a conversion into another canal type of BPPV without intervening periods of remission. In contrast, recurrence was defined as a redevelopment of any type of BPPV after a confirmed resolution of the positioning nystagmus and vertigo.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Gufoni Maneuver</title>
          <description>Gufoni maneuver for apogeotropic HC-BPPV</description>
        </group>
        <group group_id="P2">
          <title>Headshaking Maneuver</title>
          <description>headshaking maneuver for apogeotropic HC BPPV</description>
        </group>
        <group group_id="P3">
          <title>Sham Maneuver</title>
          <description>sham maneuver for apogeotropci HC BPPV</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
                <participants group_id="P2" count="54"/>
                <participants group_id="P3" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
                <participants group_id="P2" count="53"/>
                <participants group_id="P3" count="49"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Gufoni Maneuver</title>
          <description>Gufoni maneuver for apogeotropic HC-BPPV</description>
        </group>
        <group group_id="B2">
          <title>Headshaking Maneuver</title>
          <description>headshaking maneuver for apogeotropic HC BPPV</description>
        </group>
        <group group_id="B3">
          <title>Sham Maneuver</title>
          <description>sham maneuver for apogeotropci HC BPPV</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="52"/>
                <measurement group_id="B2" value="54"/>
                <measurement group_id="B3" value="51"/>
                <measurement group_id="B4" value="157"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="1"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
                <measurement group_id="B4" value="1"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="32"/>
                <measurement group_id="B2" value="30"/>
                <measurement group_id="B3" value="27"/>
                <measurement group_id="B4" value="89"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="19"/>
                <measurement group_id="B2" value="24"/>
                <measurement group_id="B3" value="24"/>
                <measurement group_id="B4" value="67"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="57.8" spread="13.5"/>
                <measurement group_id="B2" value="60.5" spread="12.4"/>
                <measurement group_id="B3" value="61.5" spread="14.9"/>
                <measurement group_id="B4" value="59.9" spread="13.6"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="39"/>
                <measurement group_id="B2" value="30"/>
                <measurement group_id="B3" value="28"/>
                <measurement group_id="B4" value="97"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="13"/>
                <measurement group_id="B2" value="24"/>
                <measurement group_id="B3" value="23"/>
                <measurement group_id="B4" value="60"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Korea, Republic of</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="52"/>
                <measurement group_id="B2" value="54"/>
                <measurement group_id="B3" value="51"/>
                <measurement group_id="B4" value="157"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo: A Randomized Clinical Trial</title>
        <description>The immediate treatment response was determined by participating neurologists in each clinic without knowing the maneuver applied to each patient from 30 minutes to one hour after initial maneuver. The absence of both vertigo and nystagmus was required to determine a resolution.</description>
        <time_frame>one hour</time_frame>
        <safety_issue>No</safety_issue>
        <population>Of the 157 patients enrolled in the study, three were lost for follow-up (dropout rate, 1.9%) and 154 were finally included for analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Gufoni Maneuver</title>
            <description>Gufoni maneuver for apogeotropic HC-BPPV</description>
          </group>
          <group group_id="O2">
            <title>Headshaking Maneuver</title>
            <description>headshaking maneuver for apogeotropic HC BPPV</description>
          </group>
          <group group_id="O3">
            <title>Sham Maneuver</title>
            <description>sham maneuver for apogeotropci HC BPPV</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="52"/>
                  <measurement group_id="O2" value="53"/>
                  <measurement group_id="O3" value="49"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo: A Randomized Clinical Trial</title>
            <description>The immediate treatment response was determined by participating neurologists in each clinic without knowing the maneuver applied to each patient from 30 minutes to one hour after initial maneuver. The absence of both vertigo and nystagmus was required to determine a resolution.</description>
            <units>participants</units>
            <param>Number</param>
            <dispersion>95% Confidence Interval</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="38" lower_limit="2.48" upper_limit="13.78"/>
                  <measurement group_id="O2" value="33" lower_limit="1.42" upper_limit="7.17"/>
                  <measurement group_id="O3" value="17" lower_limit="1.78" upper_limit="9.85"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Gufoni Maneuver</title>
          <description>Gufoni maneuver for apogeotropic HC-BPPV</description>
        </group>
        <group group_id="E2">
          <title>Headshaking Maneuver</title>
          <description>headshaking maneuver for apogeotropic HC BPPV</description>
        </group>
        <group group_id="E3">
          <title>Sham Maneuver</title>
          <description>sham maneuver for apogeotropci HC BPPV</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>In this study, resolution of BPPV was determined using a telephone interview during the follow-ups after one week.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Treatment of apogeotropic HC BPPV</name_or_title>
      <organization>KONOS</organization>
      <phone>82 10 5538 6565</phone>
      <email>ohsun@jbnu.ac.kr</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
